Discoidin domain receptor 1, a melanoma immunomodulator
C. Lutz,
A. Lourenço,
C. Reger de Moura,
B. Louveau,
A. Marie-Cardine,
C. Lebbé,
S. Mourah
Affiliations
C. Lutz
Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France
A. Lourenço
Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France
C. Reger de Moura
Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Hôpital Saint-Louis, AP-HP, Department of Pharmacology and Tumor Genomics, Paris, France
B. Louveau
Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Hôpital Saint-Louis, AP-HP, Department of Pharmacology and Tumor Genomics, Paris, France
A. Marie-Cardine
Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France
C. Lebbé
Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Hôpital Saint-Louis, AP-HP, Department of Dermatology, Paris, France
S. Mourah
Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Hôpital Saint-Louis, AP-HP, Department of Pharmacology and Tumor Genomics, Paris, France
